An international study conducted in 20 large hospitals of EEUU, Canada, Mexico, Sweden, Peru, Bolivia y Argentina demonstrates that drugs to treat arterial hypertension do not interfere with the recovery of covid-19 and in general can be unsuccessful.
The studio, recently published in The Lancet, it is proposed to monitor the types of pharmaceuticals, the inhibitors of the enzyme converter of angiotensin, conocidos such as ACEI, and the blockers of the receptors of the angiotensin, called ARBs, podium to mitigate the complications of covid-19 or the opposite.
The arrogant investigation “a fortieth evidence” that the covid-19 patients can follow tomandolos sin miedo and empeoren their situation, says one of the participants, the cardiologist Carlos E. Alfonso, associate professor of the Faculty of Medicine Miller of the University of Miami (UM).
Related information: FALSO: Hay hospital resuscitation in Jalisco by Covid-19
Alfonso and María Carolina Delgado-Lelievre, Assistant Professor of Medicine at the Integral Center of the UM Hypertension Center, will present the results of the study.
To coordinate the dates of receipts from the participating hospitals, a center of the University of Pennsylvania (EEUU).
The study was conducted on 152 hypertensive people -90 of them EEUU– which will be included with covid-19 in the participating hospitals between 31 March and 20 August 2020 and since the beginning of its hospitalization with ACEIs or ARBs.
Of these, 75 elusive azar continue to take all their medications and 77, miscarriages of the same way, dejaron de tomarlos, both medical supervision in both cases.
No different differences between both groups as to their possible interaction with covid-19, concluded.
The students studied were hospitalized with a five-day prominence, with a media age of 62 years and 45% were women.
Eight and two of the participants’ origins are in Spanish, following the file of the study.
“More than 50% of adults in the United States have hypertension, the risk number is one for the injuries of the heart, so it is very important to determine that these drugs do not modify the risks that support them. covid-19 for a person “, says Delgado-Lelievre.
Alfonso agreed that before the studio was created it would take over ACEI’s o ARB’s can be an additional risk for hypertension that is contagious to covid-19, “debit in the form in which the virus attacks cellular receptors”, and is thought to be good for taking drugs.
Now it seems that “does not have an adverse effect”, aggregate.
The result of the study is consistent with another large scale carried out in Brazil, entitled “Brace Corona”, which were presented at the European Society of Cardiology and are published publications, according to the UM specialist.
Follow the World Health Organization (OMS), more than one in five adults in the world has elevated arterial tension, a strain that causes approximately the mitigation of all injuries due to cerebrovascular accident or cardiopathy.
The complications of hypertension are the cause of 9.4 million dysfunctions each year.